Nestled in the heart of St. Louis, this institution has carved out a reputation for producing skilled and compassionate ...

Dr. Colleen McNicholas announced her resignation late Monday on social media platforms, the same day that Margot Riphagen was ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Attention-deficit/hyperactivity disorder (ADHD) diagnoses have increased among adults in recent years, while remainin ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

Most treatments being pursued today to protect against Alzheimer’s disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research from Mass General Brigham and ...

Individuals with sickle cell disease – a chronic illness where misshapen, sticky blood cells clump together, reducing oxygen ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...

A groundbreaking study reveals that individuals with sickle cell disease show premature brain aging, appearing 14 years older ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...